Skip to main content
  • Subscribe
  • Register
  • Sign in
  • Membership
  • Insights
  • Events
  • About
  • Subscribe
  • Register
  • Sign in

Gilead Sciences

Latest Articles

2016-05-27-da-trump-large.jpg

Daily Agenda: Markets Digest Trump Nomination

Andrew Barber
Martin Shkreli, Chief Investment Officer of MSMB Capital Management

Drug Wars: The Battle to Put a Lid on Rising Prices

Khadijah M Silver

Gilead Sciences Raises $1B In Note Sale

2016-03-vitaliy-katsenelson-gilead-sciences-lab-worker-large.jpg

Gilead Sciences’ Miracle Drug Combination

Vitaliy Katsenelson

Gilead To Buy Pharmasset For $11B

Martin Shkreli, Chief Investment Officer of MSMB Capital Management

Pharmaceutical Companies Gird for Drug-Price Reckoning

Kaitlin Ugolik
Inside Gilead Sciences Inc.

Specialty Pharma Drugs Raise Difficult Issues

Khadijah M Silver
2016-02-khadijah-silver-drug-prices-hillary-clinton-large.jpg

The Race to Rein in U.S. Drug Prices

Khadijah M Silver

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

LinkedIn
X
Bluesky

develop build:2025-12-17   Login